A Canadian-based pharmaceutical company has received approval to conduct a clinical study of the psychedelic compound DMT as a treatment for stroke. Under the plan, pharmaceutical development company ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. In ...

In this era of brain augmentation, nootropics, microdosing, and alternative medicine, it might seem tempting to take your mental health concerns into your own hands. But a case report about a man who ...

The first disease-modifying therapies were introduced in the United States and Canada in the 1990s. Canada has one of the highest estimated prevalences of multiple sclerosis (MS) in the world, ...

From the dark annals of Erowid forums to Joe Rogan’s podcast studio, there’s perhaps no psychoactive drug more enigmatic — and misunderstood — than N,N-Dimethyltryptamine, better known as DMT. The ...

Neuro-pharmaceutical company, MindMed, has announced that it will begin a double-blind placebo-controlled Phase 1 clinical trial to understand how N, N-Dimethyltryptamine (DMT), the primary ...

One person’s recreational drug trip might be another’s mental health boost. Research out today finds that dimethyltryptamine, better known as DMT, could be effective at treating people’s depression.

Algernon Pharmaceuticals’ AGNPF wholly-owned Algernon NeuroScience (AGN Neuro) successfully completed dosing the third and final cohort of its Phase 1 clinical study assessing an intravenous (IV) ...

New research suggests that a single dose of the psychedelic compound DMT can reverse symptoms of depression, including loss of pleasure and cognitive decline, in mice subjected to chronic stress. The ...

From a six-person office to a team of over 500 professionals and 3,500 vessels equipped. Sponsored content: Twenty-five years ...